ABOUT
CHANGING
MEDICAL DIAGNOSTICS
Scope Fluidics S.A. is a biotechnology company engaged in designing and developing innovative projects based on microfluidic technologies in medical diagnostics and healthcare.
Scope Fluidics S.A. owns a special-purpose vehicle, Bacteromic Sp. z o.o., established to develop the BacterOMIC system designed to assess the drug susceptibility of microorganisms.
In 2022, Scope Fluidics S.A. sold to Bio-Rad the technology of its proprietary PCR|ONE system designed to the fast gene diagnostics of viruses and bacteria as part of its special-purpose vehicle Curiosity Diagnostics Sp. z o.o.
SUCCESS
BUILT ON KNOWLEDGE AND EXPERIENCE
The group’s structure is based on Scope Fluidics’ business concept and operating model which envisage the following sequence: development of an innovative project, its development within a special purpose vehicle, and then selling to a global entity.
The innovative products developed within Scope Fluidics respond to important social needs, such as fast, effective and accessible medical diagnostics improving the quality of treatment and reducing the time and cost of potential hospitalisation.
WHAT MAKES US DIFFERENT
Creativity built on experience and knowledge
combining new ideas with responsibility for the results and with effectiveness of the implemented solutions
Multidisciplinary teams with broad competences
in scientific, technical and managerial fields
Effectiveness and speed
in terms of our own projects as well as the development and optimisation of existing solutions offered by other market players
Know-how in the implementation of biotechnological solutions in production
supported by the knowledge and experience of experts from the Advisory Committee
Extensive laboratory, workshop and production infrastructure
providing full control over the quality of the solutions developed
Extensive experience in patent registration
cooperation with lawyers, patent attorneys and intellectual property specialists
DISCOVER OUR SUCCESS STORY
2010
Piotr Garstecki and Marcin Izydorzak found the company Scope Fluidics
2011
first contract to develop a prototype of the device Point of Care for medical diagnostics
2012
Curiosity Diagnostics is established
2013
completion of the first contract – the Point of Care device for medical diagnostics
2015
completion of the second contract – the Point of Care device for medical diagnostics, with pilot line for manufacturing disposable cartridges
2016
start of conceptual work on the BacterOMIC system at Scope Fluidics
2017
16 AUGUST
the company Bacteromic is established
25 AUGUST
The US grants patent for technology that is key to PCR|ONE operation, allowing ultra-fast PCR to be performed on multiple samples simultaneously, and integrating PCR and detection of reaction products into a single module
2 OCTOBER
completion of Phase 1 of the BacterOMIC project “Development of a prototype device, a panel and a pilot filling and closing line for panels”
2018
AUGUST
first tests of the BacterOMIC system begin in cooperation with Poland’s National Medicines Institute
DECEMBER
he company appoints an Advisory Board comprising world-class specialists in diagnostics, microbiology and bacterial infections who are also experienced and commercially successful entrepreneurs
2019
JANUARY
the BacterOMIC system confirms its effectiveness, passing first validation tests
2020
JULY
The European Union grants first patent for the BacterOMIC system
for technology of rapid determination of antibiotic resistance in bacteria
SEPTEMBER
the company obtains financing from the European Investment Bank
OCTOBER
Professor Carl Wittwer, pioneer of molecular diagnostics and one of the inventors of PCR technology, joined the company’s Advisory Board
2021
APRIL
the ultra-fast PCR|ONE system receives European CE IVD certification for diagnosis of methicillin-resistant Staphylococcus aureus
APRIL
the PCR|ONE system with the SARS-CoV-2 panel obtains European CE-IVD certification, which allows it to be placed on the European market
OCTOBER
the BacterOMIC system obtains the European CE-IVD certificate, allowing it to be marketed in the European Union countries
2022
APRIL/MAY
completion of certification testing for the SARS-CoV-2 and MRSA/MSSA panels of the PCR|ONE system adapted for scale-up production
MAY
completion of validation of the expanded diagnostic panel of the BacterOMIC system
JUNE
launch of distribution of the PCR|ONE system
AUGUST
Bio-Rad Laboratories acquire Curiosity Diagnostics
2023
JANUARY
Scope Fluidics debuted on Warsaw Stock Exchange Main Market
SUSTAINABILITY
Caring about working and development standards of our projects in accordance with sustainability is one of the key elements of Scope Fluidics’ operation.
We implement and apply solutions to reduce the negative impact of our activities on the environment.
We apply pro-environmental solutions in our daily work, being fully aware that even the smallest initiatives, such as waste segregation, energy and water saving in the workplace, add up to environmental gains on a global scale.
QUALITY
STANDARDS
The high quality and operational reliability of our products are the benchmarks to which we absolutely aspire in our development work.
Therefore, our procedures at particular stages of conception and construction, as well as the functional quality of the resulting systems and equipment, are subject to independent audits.
These are confirmed by the quality certificates we have obtained.
See our certificates:
